Furthermore, UA‐treated CD8+ CTLs exhibited a metabolic feature that enhanced T cell stemness for cancer therapy,[37] displaying an enhanced spare respiratory capacity (Figure 6C) and reduced mitochondrial membrane potential (Figure 6F). This evidence concerns the gene CD8A and cancer.